Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets... Show more
The Aroon Indicator for PEN entered a downward trend on March 20, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 187 similar instances where the Aroon Indicator formed such a pattern. In of the 187 cases the stock moved lower. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PEN as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for PEN turned negative on March 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where PEN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
PEN moved above its 50-day moving average on April 02, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PEN crossed bullishly above the 50-day moving average on March 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PEN advanced for three days, in of 329 cases, the price rose further within the following month. The odds of a continued upward trend are .
PEN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.138) is normal, around the industry mean (23.715). P/E Ratio (93.703) is within average values for comparable stocks, (83.458). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (8.052) is also within normal values, averaging (41.612).
a manufacturer of medical devices
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DLS | 65.17 | -1.05 | -1.58% |
WisdomTree International SmallCp Div ETF | |||
SCD | 15.43 | -0.65 | -4.03% |
LMP Capital and Income Fund | |||
BLCV | 31.36 | -1.33 | -4.08% |
iShares Large Cap Value Active ETF | |||
LEXI | 28.33 | -1.30 | -4.37% |
Alexis Practical Tactical ETF | |||
DFUV | 39.30 | -2.22 | -5.35% |
Dimensional US Marketwide Value ETF |
A.I.dvisor indicates that over the last year, PEN has been loosely correlated with BIO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PEN jumps, then BIO could also see price increases.
Ticker / NAME | Correlation To PEN | 1D Price Change % | ||
---|---|---|---|---|
PEN | 100% | -1.48% | ||
BIO - PEN | 38% Loosely correlated | -4.39% | ||
MMSI - PEN | 34% Loosely correlated | -2.88% | ||
NVST - PEN | 33% Loosely correlated | -8.05% | ||
BSX - PEN | 33% Loosely correlated | -1.55% | ||
ISRG - PEN | 32% Poorly correlated | -2.45% | ||
More |